secwatch.observer — SEC 8-K summary
======================================

Issuer:     STANDARD BIOTOOLS INC. (LAB)
CIK:        0001162194
Form:       8-K
Filed at:   2022-03-29T23:59:59+00:00
Accession:  0001193125-22-087550
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fluidigm secures Caligan support for $250M Casdin/Viking capital infusion; appoints Frank Witney to board
--------------------------------------------------------------------------------

- Caligan, largest common holder, agrees to vote FOR all proposals at special meeting reconvening April 1, 2022.
- $250M strategic capital infusion from Casdin Capital and Viking Global to fund growth.
- Board will appoint Frank Witney (former Affymetrix CEO) as director, conditional on transaction close.
- Board expands to eight directors upon appointment of Witney.
- Company urges all stockholders to vote FOR; transaction terminated if not approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1162194/000119312522087550/0001193125-22-087550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1162194/000119312522087550/d325093d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-087550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer